 Edward Gill
Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography, Three-Dimensional | 8 | 2022 | 71 | 2.020 |
Why?
| | Echocardiography, Transesophageal | 7 | 2022 | 133 | 1.200 |
Why?
| | Heart Septal Defects, Atrial | 6 | 2007 | 59 | 1.110 |
Why?
| | Vena Cava, Inferior | 1 | 2025 | 81 | 0.860 |
Why?
| | Radiography, Interventional | 3 | 2020 | 130 | 0.840 |
Why?
| | Heart Atria | 3 | 2024 | 144 | 0.670 |
Why?
| | Vascular Fistula | 2 | 2024 | 22 | 0.630 |
Why?
| | Ventricular Function, Left | 3 | 2025 | 541 | 0.620 |
Why?
| | Heart Defects, Congenital | 3 | 2020 | 914 | 0.520 |
Why?
| | Multimodal Imaging | 4 | 2024 | 129 | 0.520 |
Why?
| | Heart Valve Prosthesis Implantation | 2 | 2019 | 197 | 0.470 |
Why?
| | Heart Diseases | 2 | 2019 | 350 | 0.460 |
Why?
| | Atrial Function, Right | 1 | 2015 | 14 | 0.450 |
Why?
| | Iatrogenic Disease | 1 | 2015 | 76 | 0.420 |
Why?
| | Endocarditis | 1 | 2014 | 39 | 0.410 |
Why?
| | Heart Ventricles | 2 | 2017 | 760 | 0.400 |
Why?
| | Cardiac Catheterization | 3 | 2024 | 560 | 0.400 |
Why?
| | Cardiovascular Diseases | 1 | 2025 | 2171 | 0.380 |
Why?
| | Ventricular Remodeling | 2 | 2025 | 276 | 0.300 |
Why?
| | Calcinosis | 1 | 2010 | 234 | 0.270 |
Why?
| | Coronary Vessels | 1 | 2010 | 251 | 0.270 |
Why?
| | Echocardiography, Doppler, Color | 2 | 2019 | 38 | 0.260 |
Why?
| | Ischemic Attack, Transient | 1 | 2007 | 71 | 0.250 |
Why?
| | Atherosclerosis | 1 | 2010 | 409 | 0.230 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 439 | 0.230 |
Why?
| | Fluoroscopy | 3 | 2020 | 176 | 0.220 |
Why?
| | Ultrasonography | 2 | 2025 | 770 | 0.210 |
Why?
| | Fistula | 1 | 2024 | 48 | 0.210 |
Why?
| | Calcium | 1 | 2010 | 1184 | 0.200 |
Why?
| | Surgery, Computer-Assisted | 1 | 2024 | 84 | 0.200 |
Why?
| | Prosthesis Implantation | 1 | 2005 | 153 | 0.200 |
Why?
| | Point-of-Care Systems | 1 | 2025 | 187 | 0.190 |
Why?
| | Migraine Disorders | 1 | 2005 | 112 | 0.190 |
Why?
| | Dyspnea | 1 | 2005 | 251 | 0.190 |
Why?
| | Heart Injuries | 1 | 2023 | 42 | 0.190 |
Why?
| | Myocarditis | 1 | 2023 | 102 | 0.180 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2025 | 359 | 0.180 |
Why?
| | Septal Occluder Device | 2 | 2024 | 37 | 0.170 |
Why?
| | Heart Rate | 1 | 2025 | 855 | 0.160 |
Why?
| | Humans | 21 | 2025 | 144957 | 0.150 |
Why?
| | Tomography, X-Ray Computed | 1 | 2010 | 2738 | 0.150 |
Why?
| | Echocardiography | 2 | 2020 | 652 | 0.150 |
Why?
| | Stroke Volume | 2 | 2025 | 651 | 0.150 |
Why?
| | Pulmonary Artery | 1 | 2024 | 1134 | 0.140 |
Why?
| | Ultrasonography, Interventional | 1 | 2020 | 160 | 0.140 |
Why?
| | Mitral Valve Insufficiency | 1 | 2019 | 72 | 0.140 |
Why?
| | Stroke | 1 | 2007 | 1258 | 0.140 |
Why?
| | Treatment Outcome | 6 | 2025 | 11695 | 0.120 |
Why?
| | Angioplasty | 1 | 2016 | 50 | 0.120 |
Why?
| | Aneurysm, False | 1 | 2016 | 45 | 0.110 |
Why?
| | Aortic Aneurysm | 1 | 2016 | 70 | 0.110 |
Why?
| | Prostheses and Implants | 2 | 2005 | 141 | 0.100 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 2118 | 0.100 |
Why?
| | Aorta, Thoracic | 1 | 2016 | 286 | 0.100 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2016 | 228 | 0.100 |
Why?
| | Prognosis | 2 | 2017 | 4293 | 0.080 |
Why?
| | Contraindications | 1 | 2007 | 91 | 0.070 |
Why?
| | Atrial Appendage | 1 | 2007 | 35 | 0.060 |
Why?
| | Middle Aged | 6 | 2025 | 35928 | 0.060 |
Why?
| | Embolism, Paradoxical | 1 | 2005 | 1 | 0.060 |
Why?
| | Aged | 4 | 2025 | 25947 | 0.050 |
Why?
| | Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2025 | 36 | 0.050 |
Why?
| | Hepatopulmonary Syndrome | 1 | 2005 | 23 | 0.050 |
Why?
| | Risk Factors | 2 | 2019 | 10792 | 0.050 |
Why?
| | Coronary Circulation | 1 | 2005 | 136 | 0.050 |
Why?
| | Potassium Channels | 1 | 2025 | 145 | 0.050 |
Why?
| | Catheterization | 1 | 2005 | 183 | 0.050 |
Why?
| | Heart Failure | 1 | 2017 | 2323 | 0.050 |
Why?
| | Syndrome | 1 | 2005 | 380 | 0.050 |
Why?
| | Pulmonary Veins | 1 | 2005 | 105 | 0.050 |
Why?
| | Posture | 1 | 2005 | 196 | 0.050 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2025 | 250 | 0.050 |
Why?
| | Cardiovascular Agents | 1 | 2025 | 164 | 0.050 |
Why?
| | Thrombosis | 1 | 2007 | 393 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2025 | 244 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2016 | 2920 | 0.050 |
Why?
| | Vitamin E | 1 | 2003 | 121 | 0.050 |
Why?
| | Disease Progression | 1 | 2010 | 2852 | 0.040 |
Why?
| | Contrast Media | 1 | 2005 | 488 | 0.040 |
Why?
| | Ascorbic Acid | 1 | 2003 | 180 | 0.040 |
Why?
| | Arginine | 1 | 2003 | 262 | 0.040 |
Why?
| | Atrial Fibrillation | 1 | 2007 | 550 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2003 | 331 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2029 | 0.040 |
Why?
| | Male | 5 | 2025 | 72406 | 0.040 |
Why?
| | Anatomic Landmarks | 1 | 2019 | 31 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2019 | 45 | 0.040 |
Why?
| | Mitral Valve | 1 | 2019 | 96 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2019 | 122 | 0.030 |
Why?
| | Hypoxia | 1 | 2005 | 1199 | 0.030 |
Why?
| | Female | 6 | 2025 | 78376 | 0.030 |
Why?
| | Phenotype | 1 | 2025 | 3164 | 0.030 |
Why?
| | Long Term Adverse Effects | 1 | 2016 | 13 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2003 | 965 | 0.030 |
Why?
| | Aortography | 1 | 2016 | 52 | 0.030 |
Why?
| | Vascular Access Devices | 1 | 2016 | 30 | 0.030 |
Why?
| | Surgical Instruments | 1 | 2016 | 51 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2019 | 8279 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1990 | 0.030 |
Why?
| | Computed Tomography Angiography | 1 | 2016 | 145 | 0.030 |
Why?
| | Vaccination | 1 | 2023 | 1423 | 0.030 |
Why?
| | Aftercare | 1 | 2016 | 224 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2925 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2019 | 17101 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2003 | 2584 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 6434 | 0.020 |
Why?
| | Adult | 3 | 2019 | 40506 | 0.020 |
Why?
| | Young Adult | 1 | 2023 | 14126 | 0.010 |
Why?
| | Adolescent | 1 | 2023 | 22453 | 0.010 |
Why?
| | Premenopause | 1 | 2003 | 123 | 0.010 |
Why?
| | Forearm | 1 | 2003 | 140 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2003 | 413 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 2003 | 514 | 0.010 |
Why?
| | Administration, Oral | 1 | 2003 | 848 | 0.010 |
Why?
| | Vasodilation | 1 | 2003 | 523 | 0.010 |
Why?
| | United States | 1 | 2016 | 15988 | 0.010 |
Why?
|
|
Gill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|